SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001047469-16-016901
Filing Date
2016-11-22
Accepted
2016-11-22 10:57:26
Documents
4
Period of Report
2016-12-29

Document Format Files

Seq Description Document Type Size
1 PREM14A a2230357zprem14a.htm PREM14A 771038
2 G981690.JPG g981690.jpg GRAPHIC 19823
3 G219452BGI001.GIF g219452bgi001.gif GRAPHIC 171433
4 G219452BGI002.GIF g219452bgi002.gif GRAPHIC 189872
  Complete submission text file 0001047469-16-016901.txt   1297250
Mailing Address P.O. BOX 1305 PAOLI NY 19301
Business Address P.O. BOX 1305 PAOLI NY 19301 610-889-9900
TETRALOGIC PHARMACEUTICALS Corp (Filer) CIK: 0001361248 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREM14A | Act: 34 | File No.: 001-36208 | Film No.: 162012058
SIC: 2834 Pharmaceutical Preparations